Skip to main content

Table 2 Clinicopathological characteristics of the 162 patients in association with P-cadherin expression

From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study

 

P-cadherin

 

Variable

Low

High

P-value

Age, mean ± SD (years)

55.8 ± 11.5

55.7 ± 12.9

.428

PS (no.)

  

.627

  0

52

67

 

  1

11

20

 

  2 or 3

4

8

 

CA125 a(no.)

  

.262

  ≤136

37

42

 

  > 136

30

51

 

  NA

0

2

 

Stage b(FIGO2014) (no.)

  

.0024*

  Stage I/II

46

42

 

  Stage III/IV

21

53

 

Peritoneal dissemination (no.)

  

2.7e-5*

  Positive

18

58

 

  Negative

49

37

 

Lymph node metastasis b(no.)

  

.823

  Positive

9

15

 

  Negative

58

80

 

Distant site metastasis (no.)

  

.048*

  Positive

1

9

 

  Negative

65

86

 

Histologic typeb (no.)

  

1.37e-10*

  Clear cell

30

4

 

  Endometrioid

9

21

 

  Mucinous

12

11

 

  Serous

16

59

 
  1. Clinicopathological characteristics of the 162 patients in association with P-cadherin expression
  2. *P < 0.05. aCutoff value as the median value. bPathological diagnosis. NA not available